Likarda on its life-saving dog diabetes treatment: Our competition is euthanasia
Tuesday, November 7, 2017
Posted by: Startland News
An animal’s diabetes diagnosis comes with a heavy burden for the pet’s owners, Lisa Stehno-Bittel said.
And it’s not just the cost of treatment, the president and co-founder of Likarda added.
“Of those who will try twice-daily insulin injections, within a year, half of those have given up,” she said. “A lot of that is because they’re doing everything the can — doing everything the vet tells them to do — and the animal is still failing. They’re going blind. They can’t hold their urine.”
Likarda, a Kansas City biotech research startup, has developed a better way to manage diabetes in dogs, using an injectable transplant and patented coating system, Stehno-Bittel said. The product provides a minimally invasive, long-term, cost-effective treatment with less burden on owners and the pets themselves, she said.
The firm recently attracted its first angel investment — $4 million in Series A funding from Werth Family Investment Associates— and relocated to a new workspace in a former Marion Laboratories property. The moves allow Likarda to significantly scale up its operations as it prepares to take its technology to market.
By: Tommy Felts - November 07, 2017